These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 20217516)
1. Prevention of beta-cell destruction in autoimmune diabetes: current approaches and future prospects. Sedimbi SK; Sanjeevi CB Adv Exp Med Biol; 2010; 654():611-26. PubMed ID: 20217516 [TBL] [Abstract][Full Text] [Related]
2. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives. Fändrich F; Ungefroren H Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518 [TBL] [Abstract][Full Text] [Related]
3. Acceleration of autoimmune diabetes in Rheb-congenic NOD mice with β-cell-specific mTORC1 activation. Sasaki H; Yasuda H; Moriyama H; Nakamura A; Shimizu M; Arai T; Nagata M; Hara K; Yokono K Biochem Biophys Res Commun; 2011 May; 408(2):306-11. PubMed ID: 21513702 [TBL] [Abstract][Full Text] [Related]
4. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice. Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235 [TBL] [Abstract][Full Text] [Related]
6. Beta Cell Therapies for Preventing Type 1 Diabetes: From Bench to Bedside. Brawerman G; Thompson PJ Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33339173 [TBL] [Abstract][Full Text] [Related]
7. New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes. Cabello-Olmo M; Araña M; Radichev I; Smith P; Huarte E; Barajas M Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561568 [TBL] [Abstract][Full Text] [Related]
8. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model. Zhao Y; Guo C; Hwang D; Lin B; Dingeldein M; Mihailescu D; Sam S; Sidhwani S; Zhang Y; Jain S; Skidgel RA; Prabhakar BS; Mazzone T; Holterman MJ Biochem Biophys Res Commun; 2010 Sep; 399(4):629-36. PubMed ID: 20691153 [TBL] [Abstract][Full Text] [Related]
9. T-lymphocyte recognition of beta cells in type 1 diabetes: clinical perspectives. Boitard C Diabetes Metab; 2013 Dec; 39(6):459-66. PubMed ID: 24139825 [TBL] [Abstract][Full Text] [Related]
10. Immune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD Mice. Gagliani N; Jofra T; Posgai AL; Atkinson MA; Battaglia M PLoS One; 2015; 10(11):e0142318. PubMed ID: 26580221 [TBL] [Abstract][Full Text] [Related]
11. Beyond the hormone: insulin as an autoimmune target in type 1 diabetes. Brezar V; Carel JC; Boitard C; Mallone R Endocr Rev; 2011 Oct; 32(5):623-69. PubMed ID: 21700723 [TBL] [Abstract][Full Text] [Related]
12. A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice. Gill RG; Pagni PP; Kupfer T; Wasserfall CH; Deng S; Posgai A; Manenkova Y; Bel Hani A; Straub L; Bernstein P; Atkinson MA; Herold KC; von Herrath M; Staeva T; Ehlers MR; Nepom GT Diabetes; 2016 May; 65(5):1310-6. PubMed ID: 26718498 [TBL] [Abstract][Full Text] [Related]
13. B7-H4.Ig inhibits the development of type 1 diabetes by regulating Th17 cells in NOD mice. Lee IF; Wang X; Hao J; Akhoundsadegh N; Chen L; Liu L; Langermann S; Ou D; Warnock GL Cell Immunol; 2013 Mar; 282(1):1-8. PubMed ID: 23623902 [TBL] [Abstract][Full Text] [Related]
14. Immunomodulation and regeneration of islet Beta cells by cytokines in autoimmune type 1 diabetes. Singh B; Nikoopour E; Huszarik K; Elliott JF; Jevnikar AM J Interferon Cytokine Res; 2011 Oct; 31(10):711-9. PubMed ID: 21851268 [TBL] [Abstract][Full Text] [Related]
15. Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice. Koulmanda M; Bhasin M; Hoffman L; Fan Z; Qipo A; Shi H; Bonner-Weir S; Putheti P; Degauque N; Libermann TA; Auchincloss H; Flier JS; Strom TB Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16242-7. PubMed ID: 18852471 [TBL] [Abstract][Full Text] [Related]
16. Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes. Sherry NA; Kushner JA; Glandt M; Kitamura T; Brillantes AM; Herold KC Diabetes; 2006 Dec; 55(12):3238-45. PubMed ID: 17130466 [TBL] [Abstract][Full Text] [Related]
18. Autoimmunity and beta cell regeneration in mouse and human type 1 diabetes: the peace is not enough. Ablamunits V; Sherry NA; Kushner JA; Herold KC Ann N Y Acad Sci; 2007 Apr; 1103():19-32. PubMed ID: 17376841 [TBL] [Abstract][Full Text] [Related]
19. B cell therapy is β-tested: Rituximab puts a pause on β-cell destruction. Clynes R Islets; 2010; 2(2):130-2. PubMed ID: 21099307 [No Abstract] [Full Text] [Related]
20. Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase. Jun HS; Chung YH; Han J; Kim A; Yoo SS; Sherwin RS; Yoon JW Diabetologia; 2002 May; 45(5):668-76. PubMed ID: 12107747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]